Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Net Sales
14,277.64
12,207.44
10,260.44
8,749.43
7,781.56
6,214.43
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
14,277.64
12,207.44
10,260.44
8,749.43
7,781.56
6,214.43
Raw Material Cost
2,288.03
2,016.35
1,842.29
1,813.66
2,057.56
1,373.18
Purchase of Finished goods
1,727.97
1,655.69
1,409.85
809.24
813.75
654.83
(Increase) / Decrease In Stocks
36.12
-183.00
-53.67
290.74
-449.59
-247.40
Employee Cost
3,183.90
2,692.37
2,260.60
1,918.47
1,620.59
1,415.78
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
3,424.21
3,008.10
2,287.69
2,016.69
1,749.88
1,369.94
Total Expenditure (Excl Depreciation)
10,660.23
9,189.51
7,746.76
6,848.80
5,792.20
4,566.33
Operating Profit (PBDIT) excl Other Income
3,617.41
3,017.93
2,513.68
1,900.63
1,989.36
1,648.10
Other Income
358.79
536.79
280.22
128.57
196.03
170.95
Operating Profit (PBDIT)
3,976.20
3,554.72
2,793.90
2,029.20
2,185.39
1,819.05
Interest
639.28
429.41
32.75
44.47
58.61
20.15
Exceptional Items
-129.75
4.53
0.98
0.00
0.00
0.00
Gross Profit (PBDT)
3,207.17
3,125.31
2,761.15
1,984.73
2,126.78
1,798.90
Depreciation
886.18
621.22
378.42
325.92
166.62
118.97
Profit Before Tax
2,320.99
2,504.09
2,382.73
1,658.82
1,960.15
1,679.93
Tax
394.58
509.74
457.15
361.56
521.64
398.58
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,926.41
1,994.35
1,925.58
1,297.26
1,438.51
1,281.35
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
4.53
0.98
0.00
0.00
0.00
Net Profit
1,926.41
1,998.88
1,926.56
1,297.26
1,438.51
1,281.35
Share in Profit of Associates
11.69
12.24
15.21
12.42
14.45
11.68
Minority Interest
-25.17
-20.16
-28.87
-27.82
-19.48
-27.61
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,912.93
1,990.96
1,912.90
1,281.86
1,433.48
1,265.43
Equity Capital
41.28
41.26
40.06
40.06
40.06
45.06
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
16,259.06
14,291.13
9,323.03
7,395.16
6,115.17
0.00
Earnings per share (EPS)
46.34
48.25
47.75
32.0
35.78
28.08
Diluted Earnings per share
46.28
49.19
47.68
32.0
35.78
32.28
Operating Profit Margin (Excl OI)
25.34%
24.72%
24.5%
21.72%
25.57%
26.52%
Gross Profit Margin
22.46%
25.6%
26.91%
22.68%
27.33%
28.95%
PAT Margin
13.57%
16.44%
18.92%
14.97%
18.67%
20.81%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 16.96% vs 18.98% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is -3.92% vs 4.08% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 19.86% vs 20.06% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 48.87% vs 1,211.18% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Mankind Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
14,277.64
22,707.90
-8,430.26
-37.12%
Other Operating Income
0.00
0.00
0.00
Total Operating income
14,277.64
22,707.90
-8,430.26
-37.12%
Raw Material Cost
2,288.03
4,457.41
-2,169.38
-48.67%
Purchase of Finished goods
1,727.97
2,642.62
-914.65
-34.61%
(Increase) / Decrease In Stocks
36.12
-257.78
293.90
114.01%
Employee Cost
3,183.90
3,964.20
-780.30
-19.68%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
3,424.21
6,618.14
-3,193.93
-48.26%
Total Expenditure (Excl Depreciation)
10,660.23
17,424.59
-6,764.36
-38.82%
Operating Profit (PBDIT) excl Other Income
3,617.41
5,283.31
-1,665.90
-31.53%
Other Income
358.79
195.82
162.97
83.22%
Operating Profit (PBDIT)
3,976.20
5,479.13
-1,502.93
-27.43%
Interest
639.28
294.87
344.41
116.80%
Exceptional Items
-129.75
0.00
-129.75
Gross Profit (PBDT)
3,207.17
5,184.26
-1,977.09
-38.14%
Depreciation
886.18
1,169.26
-283.08
-24.21%
Profit Before Tax
2,320.99
4,015.00
-1,694.01
-42.19%
Tax
394.58
708.74
-314.16
-44.33%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
1,926.41
3,306.26
-1,379.85
-41.73%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
1,926.41
3,306.26
-1,379.85
-41.73%
Share in Profit of Associates
11.69
0.00
11.69
Minority Interest
-25.17
-24.64
-0.53
-2.15%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,912.93
3,281.62
-1,368.69
-41.71%
Equity Capital
41.28
91.32
-50.04
-54.80%
Face Value
1.00
2.00
0.00
Reserves
16,259.06
17,112.18
-853.12
-4.99%
Earnings per share (EPS)
46.34
71.87
-25.53
-35.52%
Diluted Earnings per share
46.28
71.69
-25.41
-35.44%
Operating Profit Margin (Excl OI)
25.34%
23.81%
0.00
1.53%
Gross Profit Margin
22.46%
23.36%
0.00
-0.90%
PAT Margin
13.57%
14.90%
0.00
-1.33%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 14,277.64 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 16.96% vs 18.98% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 1,912.93 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -3.92% vs 4.08% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3,617.41 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 19.86% vs 20.06% in Mar 2025
Annual - Interest
Interest 639.28 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 48.87% vs 1,211.18% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.34%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
